{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:50:57Z","timestamp":1790272257589,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.blre.2019.100595","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:58:05Z","timestamp":1565229485000},"page":"100595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["The emerging role of exosomes in multiple myeloma"],"prefix":"10.1016","volume":"38","author":[{"given":"Milad","family":"Moloudizargari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina Andreea","family":"Zimta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Berindan","family":"Neagoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.blre.2019.100595_bb0005","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2014-11-568881","article-title":"Pathogenesis beyond the cancer clone(s) in multiple myeloma","volume":"125","author":"Bianchi","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2019.100595_bb0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2018-09-825331","article-title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","volume":"133","author":"Pawlyn","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2019.100595_bb0015","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood-2011-06-297853","article-title":"Approach to the treatment of multiple myeloma: a clash of philosophies","volume":"118","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.blre.2019.100595_bb0020","doi-asserted-by":"crossref","first-page":"30876","DOI":"10.18632\/oncotarget.9021","article-title":"Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.blre.2019.100595_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coph.2016.02.013","article-title":"New approaches to targeting the bone marrow microenvironment in multiple myeloma","volume":"28","author":"Gooding","year":"2016","journal-title":"Curr Opin Pharmacol"},{"issue":"15","key":"10.1016\/j.blre.2019.100595_bb0030","doi-asserted-by":"crossref","first-page":"13772","DOI":"10.18632\/oncotarget.3830","article-title":"Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation","volume":"6","author":"Raimondi","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2014-03-562439","article-title":"Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2019.100595_bb0040","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2019.100595_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.phrs.2018.07.001","article-title":"Modifying exosome release in cancer therapy: how can it help?","volume":"134","author":"Moloudizargari","year":"2018","journal-title":"Pharmacol Res"},{"issue":"23","key":"10.1016\/j.blre.2019.100595_bb0050","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood-2016-05-715961","article-title":"Caspase-3-dependent cleavage of Bcl-xL in the stroma exosomes is required for their uptake by hematological malignant cells","volume":"128","author":"Vardaki","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2019.100595_bb0055","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2016.04.024","article-title":"Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity","volume":"377","author":"De Veirman","year":"2016","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0065","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0070","first-page":"356","article-title":"Kruppel-like factor 8 promotes tumorigenic mammary stem cell induction by targeting miR-146a","volume":"3","author":"Wang","year":"2013","journal-title":"Am J Cancer Res"},{"issue":"2","key":"10.1016\/j.blre.2019.100595_bb0075","first-page":"192","article-title":"Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model","volume":"91","author":"Yaccoby","year":"2006","journal-title":"Haematologica"},{"issue":"19","key":"10.1016\/j.blre.2019.100595_bb0080","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/23808993.2019.1606672","article-title":"The treatment of multiple myeloma in an era of precision medicine","volume":"4","author":"Kint","year":"2019","journal-title":"Expert Rev Precision Med Drug Dev"},{"issue":"20","key":"10.1016\/j.blre.2019.100595_bb0090","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2014-11-568923","article-title":"Treatment options for relapsed and refractory multiple myeloma","volume":"125","author":"Nooka","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2019.100595_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139867","article-title":"PDL1 expression on plasma and dendritic cells in myeloma bone marrow suggests benefit of targeted anti PD1-PDL1 therapy","volume":"10","author":"Sponaas","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/asheducation-2017.1.518","article-title":"Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies","volume":"2017","author":"Kumar","year":"2017","journal-title":"Hematol-Am Soc Hematol"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0105","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/leu.2017.91","article-title":"The emerging roles of tumor-derived exosomes in hematological malignancies","volume":"31","author":"Boyiadzis","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.blre.2019.100595_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Th\u00e9ry","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0115","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/14737159.2016.1132627","article-title":"The potential diagnostic power of extracellular vesicle analysis for multiple myeloma","volume":"16","author":"Canella","year":"2016","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12185-017-2180-x","article-title":"Extracellular vesicles and blood diseases","volume":"105","author":"Nomura","year":"2017","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1021\/acs.bioconjchem.8b00003","article-title":"Exosomes-small players, big sound","volume":"29","author":"Gulei","year":"2018","journal-title":"Bioconjug Chem"},{"issue":"24","key":"10.1016\/j.blre.2019.100595_bb0135","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1007\/s00018-016-2309-8","article-title":"PIKfyve inhibition increases exosome release and induces secretory autophagy","volume":"73","author":"Hessvik","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"24","key":"10.1016\/j.blre.2019.100595_bb0140","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J Cell Sci"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061196","article-title":"Peptidylarginine deiminases\u2014roles in cancer and neurodegeneration and possible avenues for therapeutic intervention via modulation of exosome and microvesicle (EMV) release?","volume":"18","author":"Lange","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.blre.2019.100595_bb0150","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/acs.langmuir.5b00095","article-title":"Analysis of exosome release as a cellular response to MAPK pathway inhibition","volume":"31","author":"Agarwal","year":"2015","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.blre.2019.100595_bb0155","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2014.04.009","article-title":"Sorting it out: regulation of exosome loading","volume":"28","author":"Villarroya-Beltri","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-13-256","article-title":"Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer","volume":"13","author":"Singh","year":"2014","journal-title":"Mol Cancer"},{"issue":"5","key":"10.1016\/j.blre.2019.100595_bb0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ejca.2013.12.019","article-title":"Regulation of exosome release from mammary epithelial and breast cancer cells-a new regulatory pathway","volume":"50","author":"Riches","year":"2014","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.blre.2019.100595_bb0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2502","article-title":"Syndecan\u2013syntenin\u2013ALIX regulates the biogenesis of exosomes","volume":"14","author":"Baietti","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.blre.2019.100595_bb0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/19336918.2016.1225632","article-title":"Syntenin: key player in cancer exosome biogenesis and uptake?","volume":"11","author":"Fares","year":"2017","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.blre.2019.100595_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4477","article-title":"Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2","volume":"5","author":"Ghossoub","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.blre.2019.100595_bb0190","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1055\/s-0034-1382881","article-title":"Olive leaf extracts protect cardiomyocytes against 4-hydroxynonenal-induced toxicity in vitro: comparison with oleuropein, hydroxytyrosol, and quercetin","volume":"80","author":"Bali","year":"2014","journal-title":"Planta Med"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0195","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.devcel.2017.11.018","article-title":"Atg5 disassociates the V1V0-ATPase to promote exosome production and tumor metastasis independent of canonical macroautophagy","volume":"43","author":"Guo","year":"2017","journal-title":"Dev Cell"},{"key":"10.1016\/j.blre.2019.100595_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.arr.2017.09.005","article-title":"Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases","volume":"40","author":"Moloudizargari","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0205","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1074\/jbc.M115.686295","article-title":"Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions","volume":"291","author":"Purushothaman","year":"2016","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.blre.2019.100595_bb0210","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.xphs.2017.02.030","article-title":"Pharmacokinetics of exosomes\u2014an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics","volume":"106","author":"Morishita","year":"2017","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcancer.2014.04.008","article-title":"Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation","volume":"28","author":"Altevogt","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"25","key":"10.1016\/j.blre.2019.100595_bb0220","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2014-10-607846","article-title":"Hypoxic exosomes promote angiogenesis","volume":"124","author":"Fan","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100595_bb0225","first-page":"1","article-title":"Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cdd.2014.130","article-title":"Exosomes as divine messengers: are they the hermes of modern molecular oncology?","volume":"22","author":"Braicu","year":"2015","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/fon.13.222","article-title":"Dark side of the exosome: the role of the exosome in cancer metastasis and targeting the exosome as a strategy for cancer therapy","volume":"10","author":"Kosaka","year":"2014","journal-title":"Future Oncol"},{"issue":"40","key":"10.1016\/j.blre.2019.100595_bb0240","doi-asserted-by":"crossref","first-page":"E4165","DOI":"10.1073\/pnas.1416745111","article-title":"Modeling putative therapeutic implications of exosome exchange between tumor and immune cells","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.blre.2019.100595_bb0245","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/10409238.2018.1508276","article-title":"Exosomes at a glance - common nominators for cancer hallmarks and novel diagnosis tools","volume":"53","author":"Gulei","year":"2018","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"25","key":"10.1016\/j.blre.2019.100595_bb0250","doi-asserted-by":"crossref","first-page":"38927","DOI":"10.18632\/oncotarget.7792","article-title":"Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0255","doi-asserted-by":"crossref","DOI":"10.1186\/2050-7771-2-10","article-title":"Micro-RNAs, new performers in multiple myeloma bone marrow microenvironment","volume":"2","author":"Abdi","year":"2014","journal-title":"Biomark Res"},{"issue":"37","key":"10.1016\/j.blre.2019.100595_bb0260","doi-asserted-by":"crossref","first-page":"60698","DOI":"10.18632\/oncotarget.10849","article-title":"Microenvironment drug resistance in multiple myeloma: emerging new players","volume":"7","author":"Di Marzo","year":"2016","journal-title":"Oncotarget"},{"issue":"MAR","key":"10.1016\/j.blre.2019.100595_bb0265","article-title":"NKG2D and its ligands: \"one for all, all for one\"","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.cdd.4402237","article-title":"Tumour-released exosomes and their implications in cancer immunity","volume":"15","author":"Iero","year":"2008","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12967-016-1056-9","article-title":"Exosomes in tumor microenvironment: novel transporters and biomarkers","volume":"14","author":"Wang","year":"2016","journal-title":"J Transl Med"},{"issue":"41","key":"10.1016\/j.blre.2019.100595_bb0280","doi-asserted-by":"crossref","first-page":"43992","DOI":"10.18632\/oncotarget.6083","article-title":"The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.blre.2019.100595_bb0285","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3109\/10428194.2013.788699","article-title":"Revisiting treatment paradigms in high-risk smoldering multiple myeloma: out with the old, in with the new?","volume":"54","author":"Ghobrial","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/138920109787847493","article-title":"Multiple myeloma bone marrow niche","volume":"10","author":"Basak","year":"2009","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0295","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.hoc.2007.08.007","article-title":"The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies","volume":"21","author":"Mitsiades","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0300","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404466","article-title":"Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma","volume":"21","author":"Arnulf","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.blre.2019.100595_bb0305","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.blre.2019.100595_bb0310","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-11-2212","article-title":"Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects","volume":"18","author":"Reagan","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.blre.2019.100595_bb0315","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1038\/leu.2012.126","article-title":"Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway","volume":"26","author":"Xu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2019.100595_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9012152","article-title":"Multiple myeloma-derived exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a","volume":"2017","author":"Cheng","year":"2017","journal-title":"Stem Cells Int"},{"issue":"2","key":"10.1016\/j.blre.2019.100595_bb0325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/path.4712","article-title":"Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression","volume":"239","author":"Wang","year":"2016","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.blre.2019.100595_bb0330","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2019.100595_bb0335","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2119\/molmed.2016.00198","article-title":"Adenosine generated in the bone marrow niche through a CD38-mediated pathway correlates with progression of human myeloma","volume":"22","author":"Horenstein","year":"2016","journal-title":"Mol Med"},{"issue":"8","key":"10.1016\/j.blre.2019.100595_bb0340","article-title":"Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD","volume":"7","author":"Morandi","year":"2018","journal-title":"Oncoimmunology"},{"issue":"15","key":"10.1016\/j.blre.2019.100595_bb0345","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","article-title":"ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype","volume":"113","author":"Soriani","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0350","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1615\/CritRevImmunol.2017020166","article-title":"Targeting NKG2D and NKp30 Ligands shedding to improve NK Cell-Based immunotherapy","volume":"36","author":"Zingoni","year":"2016","journal-title":"Crit Rev Immunol"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0355","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.blre.2019.100595_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00091","article-title":"Role of exosomes released by dendritic cells and\/or by tumor targets: regulation of NK cell plasticity","volume":"5","author":"Reiners","year":"2014","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.blre.2019.100595_bb0365","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2019.100595_bb0370","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fphys.2013.00056","article-title":"Contribution of bone marrow derived cells to the pancreatic tumor microenvironment","volume":"4","author":"Scarlett","year":"2013","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0375","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-017-0730-8","article-title":"Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes","volume":"16","author":"Iaccino","year":"2017","journal-title":"Mol Cancer"},{"issue":"11","key":"10.1016\/j.blre.2019.100595_bb0380","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41408-018-0139-7","article-title":"Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts","volume":"8","author":"Faict","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2019.100595_bb0385","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.matbio.2017.09.001","article-title":"Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior","volume":"65","author":"Bandari","year":"2018","journal-title":"Matrix Biol"},{"issue":"2","key":"10.1016\/j.blre.2019.100595_bb0390","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/path.4712","article-title":"Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression","volume":"239","author":"Wang","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.blre.2019.100595_bb0395","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5046953","article-title":"Structure and functions of blood vessels and vascular niches in bone","volume":"2017","author":"Ramasamy","year":"2017","journal-title":"Stem Cells Int"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0400","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MOH.0000000000000235","article-title":"Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia","volume":"23","author":"Ohyashiki","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0405","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1242\/dmm.008961","article-title":"Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models","volume":"5","author":"Hu","year":"2012","journal-title":"Dis Model Mech"},{"issue":"25","key":"10.1016\/j.blre.2019.100595_bb0410","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","article-title":"Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1","volume":"124","author":"Umezu","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.blre.2019.100595_bb0415","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/bloodadvances.2016003251","article-title":"Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis","volume":"1","author":"Umezu","year":"2017","journal-title":"Blood Adv"},{"issue":"13","key":"10.1016\/j.blre.2019.100595_bb0420","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: pathophysiology of osteoblast inhibition","volume":"108","author":"Giuliani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2019.100595_bb0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CGM.S16817","article-title":"Bone disease in multiple myeloma: pathophysiology and management","volume":"7","author":"Hameed","year":"2014","journal-title":"Cancer Growth Metastasis"},{"issue":"7","key":"10.1016\/j.blre.2019.100595_bb0430","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2326-6066.CIR-17-0604","article-title":"Drug-induced senescent multiple myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL15 trans-presentation","volume":"6","author":"Borrelli","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0435","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0440","first-page":"1713","article-title":"Effect of myeloma-derived exosomes on surface activating receptors of NK cells","volume":"25","author":"Xiong","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.blre.2019.100595_bb0445","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4049\/jimmunol.1402643","article-title":"Genotoxic stress induces senescence-associated ADAM10-dependent release of NKG2D MIC ligands in multiple myeloma cells","volume":"195","author":"Zingoni","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2019.100595_bb0450","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bios.2015.09.061","article-title":"Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes","volume":"77","author":"Di Noto","year":"2016","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.blre.2019.100595_bb0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2014.02.011","article-title":"Outsmart tumor exosomes to steal the cancer initiating cell its niche","volume":"28","author":"Thuma","year":"2014","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"10.1016\/j.blre.2019.100595_bb0460","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.3324\/haematol.2017.182865","article-title":"Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy","volume":"103","author":"Galli","year":"2018","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.blre.2019.100595_bb0465","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/1078-0432.CCR-15-2170","article-title":"TNF-related apoptosis-inducing ligand (trail)-armed exosomes deliver proapoptotic signals to tumor site","volume":"22","author":"Rivoltini","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.blre.2019.100595_bb0470","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","article-title":"Prognostic role of circulating exosomal miRNAs in multiple myeloma","volume":"129","author":"Manier","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0475","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/leu.2017.277","article-title":"Extracellular vesicles as potential biomarkers of acute graft-vs-host disease","volume":"32","author":"Lia","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.blre.2019.100595_bb0480","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1042\/BCJ20170962","article-title":"Dis3 isoforms vary in their endoribonuclease activity and are differentially expressed within haematological cancers","volume":"475","author":"Robinson","year":"2018","journal-title":"Biochem J"},{"issue":"11","key":"10.1016\/j.blre.2019.100595_bb0485","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.blre.2019.100595_bb0490","doi-asserted-by":"crossref","first-page":"A665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: a major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.blre.2019.100595_bb0495","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jcyt.2018.10.006","article-title":"Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA\/BCL-2 expression","volume":"21","author":"Deng","year":"2018","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.blre.2019.100595_bb0500","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hon.2554","article-title":"Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies","volume":"36","author":"Sedlarikova","year":"2018","journal-title":"Hematol Oncol"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0505","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1515\/cclm-2015-0994","article-title":"Laboratory testing in monoclonal gammopathy of renal significance (MGRS)","volume":"54","author":"Leung","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0510","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ijc.30672","article-title":"The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy","volume":"141","author":"Moore","year":"2017","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004942","article-title":"Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha","volume":"4","author":"Viaud","year":"2009","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.blre.2019.100595_bb0520","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11914-017-0360-5","article-title":"MicroRNA Transfer between bone marrow adipose and multiple myeloma cells","volume":"15","author":"Soley","year":"2017","journal-title":"Curr Osteoporos Rep"},{"issue":"9","key":"10.1016\/j.blre.2019.100595_bb0525","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CJI.0000000000000185","article-title":"DCOne as an allogeneic cell-based vaccine for multiple myeloma","volume":"40","author":"Leaf","year":"2017","journal-title":"J Immunother"},{"key":"10.1016\/j.blre.2019.100595_bb0530","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/1471-2164-9-340","article-title":"Comparative transcriptomics of human multipotent stem cells during adipogenesis and osteoblastogenesis","volume":"9","author":"Scheideler","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.blre.2019.100595_bb0535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fcvm.2017.00063","article-title":"Toward exosome-based therapeutics: isolation, heterogeneity, and fit-for-purpose potency","volume":"4","author":"Willis","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.blre.2019.100595_bb0540","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1248\/bpb.b18-00133","article-title":"Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application","volume":"41","author":"Yamashita","year":"2018","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.blre.2019.100595_bb0545","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2407-9-102","article-title":"Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis","volume":"9","author":"Cai","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2019.100595_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jprot.2015.12.016","article-title":"Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers","volume":"136","author":"Harshman","year":"2016","journal-title":"J Proteomics"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X19300529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X19300529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:23:20Z","timestamp":1759436600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X19300529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":110,"alternative-id":["S0268960X19300529"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2019.100595","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of exosomes in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2019.100595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100595"}}